ATE394386T1 - 2-phenylpyran-4-on-derivate als selektive cox-2 inhibitoren - Google Patents

2-phenylpyran-4-on-derivate als selektive cox-2 inhibitoren

Info

Publication number
ATE394386T1
ATE394386T1 AT04710358T AT04710358T ATE394386T1 AT E394386 T1 ATE394386 T1 AT E394386T1 AT 04710358 T AT04710358 T AT 04710358T AT 04710358 T AT04710358 T AT 04710358T AT E394386 T1 ATE394386 T1 AT E394386T1
Authority
AT
Austria
Prior art keywords
phenylpyran
derivatives
inhibitors
selective cox
cox
Prior art date
Application number
AT04710358T
Other languages
English (en)
Inventor
Javaloyes Juan Caturla
Graham Warrellow
Original Assignee
Almirall Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Lab filed Critical Almirall Lab
Application granted granted Critical
Publication of ATE394386T1 publication Critical patent/ATE394386T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/38Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Pyrane Compounds (AREA)
AT04710358T 2003-02-13 2004-02-12 2-phenylpyran-4-on-derivate als selektive cox-2 inhibitoren ATE394386T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200300355A ES2213485B1 (es) 2003-02-13 2003-02-13 Derivados de la 2-fenilpiran-4-ona.

Publications (1)

Publication Number Publication Date
ATE394386T1 true ATE394386T1 (de) 2008-05-15

Family

ID=32865136

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04710358T ATE394386T1 (de) 2003-02-13 2004-02-12 2-phenylpyran-4-on-derivate als selektive cox-2 inhibitoren

Country Status (8)

Country Link
US (1) US7582676B2 (de)
EP (1) EP1592680B9 (de)
JP (1) JP2006517560A (de)
CN (1) CN100436438C (de)
AT (1) ATE394386T1 (de)
DE (1) DE602004013542D1 (de)
ES (2) ES2213485B1 (de)
WO (1) WO2004072058A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2213485B1 (es) 2003-02-13 2005-12-16 Almirall Prodesfarma, S.A. Derivados de la 2-fenilpiran-4-ona.
ES2214129B1 (es) * 2003-02-13 2005-12-01 Almirall Prodesfarma, S.A. 3-fenilfuran-2-onas.
ES2214130B1 (es) * 2003-02-13 2005-12-01 Almirall Prodesfarma, S.A. 2-3'-bipiridinas.

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4304728A (en) * 1979-04-05 1981-12-08 Lilly Industries Limited 6-Substituted pyranone compounds and their use as pharmaceuticals
US6486194B2 (en) 1993-06-24 2002-11-26 Merck Frosst Canada, Inc. Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases
US5585504A (en) 1994-09-16 1996-12-17 Merck & Co., Inc. Process of making cox-2 inhibitors having a lactone bridge
GB2294879A (en) 1994-10-19 1996-05-15 Merck & Co Inc Cylcooxygenase-2 Inhibitors
US6231888B1 (en) 1996-01-18 2001-05-15 Perio Products Ltd. Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
ES2125161B1 (es) 1996-03-21 1999-11-16 Grupo Farmaceutico Almirall S Nuevos derivados de 2-(3h)-oxazolona.
BR9709097A (pt) 1996-05-17 1999-08-03 Merck & Co Inc Composição farmacêutica para o tratamento de doenças mediadas por ciclooxigenase processo para tratar uma doença inflamatória suscetível de tratamento com um agente antinflamatório n o esteróide uso e forma oral de dose unitária
IL127441A (en) 1996-07-18 2003-02-12 Merck Frosst Canada Inc Substituted pyridines, pharmaceutical compositions comprising them and their use in the preparation of anti-inflammatory medicaments or as selective cyclooxygenase-2 inhibitors
US6307047B1 (en) 1997-08-22 2001-10-23 Abbott Laboratories Prostaglandin endoperoxide H synthase biosynthesis inhibitors
DK1032575T3 (da) 1997-09-05 2003-10-20 Glaxo Group Ltd 2,3-diaryl-pyrazol(1,5-b)pyridazinderivater, deres fremstilling og anvendelse som cyclooxygenase 2 (COX-2) inhibitor
ES2131015B1 (es) 1997-09-12 2000-03-01 Almirall Prodesfarma Sa Nuevos derivados de 2-(3h)-oxazolona, procedimientos para su preparacion y su empleo en composiciones farmaceuticas.
US5994379A (en) 1998-02-13 1999-11-30 Merck Frosst Canada, Inc. Bisaryl COX-2 inhibiting compounds, compositions and methods of use
KR100295206B1 (ko) * 1998-08-22 2001-07-12 서경배 디아릴벤조피란유도체및이를함유하는시클로옥시게네이즈-2저해제조성물
DE69919179T2 (de) * 1998-09-09 2005-07-28 Inflazyme Pharmaceuticals, Ltd., Richmond Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
ES2154561B1 (es) * 1998-09-25 2001-12-01 Almirall Prodesfarma Sa Derivados de 2-fenilpiran-4-ona.
TW587079B (en) * 1998-09-25 2004-05-11 Almirall Prodesfarma Ag 2-phenylpyran-4-one derivatives
US6303972B1 (en) * 1998-11-25 2001-10-16 Micron Technology, Inc. Device including a conductive layer protected against oxidation
BRPI0011172B8 (pt) * 1999-04-14 2021-05-25 Pacific Corp derivados do 4,5-diaril-3(2h)-furanona como inibidores de ciclooxigenase-2
JP2003503360A (ja) 1999-06-24 2003-01-28 ファルマシア コーポレイション 炎症性疾患の処置のための併用療法
EP1104759B1 (de) 1999-12-03 2003-10-22 Pfizer Products Inc. Heteroarylphenylpyrazolverbindungen zur Verwendung als analgetisches/entzündungshemmendes Mittel
PE20011333A1 (es) * 2000-03-16 2002-01-16 Almirall Prodesfarma Ag Derivados de 2-fenilpiran-4-ona como inhibidores de ciclooxigenasa 2
CA2412651A1 (en) 2000-05-22 2001-11-29 Dr. Reddy's Laboratories Limited Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them
US20020009421A1 (en) 2000-06-01 2002-01-24 Wilder Karol J. Therapy following skin injury from exposure to ultraviolet radiation
ATE338566T1 (de) 2000-07-27 2006-09-15 Pharmacia Corp Aldosteronantagonist und cyclooxygenase-2 hemmer- kombinationstherapie zur verhinderung oder behandlung von entzündungsverwandten kardiovaskulären krankheiten
WO2002055502A1 (en) 2001-01-02 2002-07-18 Fujisawa Pharmaceutical Co., Ltd. Pyridine derivatives useful as cyclooxygenase inhibitor
WO2003006451A1 (en) 2001-07-10 2003-01-23 Almirall Prodesfarma S.A. 4-phenylpyran-2-one derivatives
PT1492773E (pt) 2002-04-05 2009-05-07 Cadila Healthcare Ltd Compostos de 4-(heterociclilo)-benzenossulfoximinapara o tratamento da inflamação
ES2214129B1 (es) 2003-02-13 2005-12-01 Almirall Prodesfarma, S.A. 3-fenilfuran-2-onas.
ES2213485B1 (es) 2003-02-13 2005-12-16 Almirall Prodesfarma, S.A. Derivados de la 2-fenilpiran-4-ona.
ES2214130B1 (es) 2003-02-13 2005-12-01 Almirall Prodesfarma, S.A. 2-3'-bipiridinas.

Also Published As

Publication number Publication date
JP2006517560A (ja) 2006-07-27
WO2004072058A1 (en) 2004-08-26
US7582676B2 (en) 2009-09-01
CN100436438C (zh) 2008-11-26
EP1592680B1 (de) 2008-05-07
EP1592680B9 (de) 2009-03-25
ES2213485A1 (es) 2004-08-16
EP1592680A1 (de) 2005-11-09
ES2303938T3 (es) 2008-09-01
US20060142380A1 (en) 2006-06-29
CN1768049A (zh) 2006-05-03
ES2303938T4 (es) 2009-06-05
ES2213485B1 (es) 2005-12-16
DE602004013542D1 (en) 2008-06-19

Similar Documents

Publication Publication Date Title
EA200970156A1 (ru) Пиридизиноновые производные
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
SE0301700D0 (sv) Novel compounds
ATE433447T1 (de) Pyrimiidinverbindungen
NO20090295L (no) Substituerte heteroarylderivater
NO20063449L (no) Substituerte heterocykler og deres anvendelse
EA200700168A1 (ru) Производные замещенной циклической мочевины, их получение и их фармацевтическое применение в качестве ингибиторов киназы
EA201170772A1 (ru) Органические соединения
MY142589A (en) Benzimidazole derivatives : preparation and pharmaceutical applications
ATE362932T1 (de) Azaindolverbindungen als kinaseinhibitoren
EA200700189A1 (ru) Производные хиназолина в качестве ингибиторов parp
NO20066055L (no) Pyridinderivater
UA86591C2 (ru) Пирролодигидроизохинолины как ингибиторы pde10, фармацевтическая композиция на их основе
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
NO20063821L (no) Kinolinderivater for anvendelse som mykobakterielle inhibitorer
MXPA05012247A (es) Derivados de bencimidazol nuevos.
NO20081001L (no) Derivater av karboksamid som antagonister for muskarinisk reseptor
ATE300541T1 (de) Pyrazolopyridinderivate
NO20063062L (no) Imidazolderivater, fremgangsmate for fremstilling og anvendelse av disse
SE0302139D0 (sv) Novel compounds
EA200601279A1 (ru) Пиперидинилкарбонилпирролидины и их применение в качестве агонистов меланокортина
UA96277C2 (en) Benzimidazole derivatives
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
NO20080650L (no) Forbindelser omfattende DMXAA for behandling av kreft
DE60222465D1 (de) Pyrazolopyridin-derivate als antiherpesmittel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties